tiprankstipranks
Advertisement
Advertisement

NSPR Stock Latest News

InspireMD Eliminates Chief Commercial Officer Position
Company AnnouncementsInspireMD Eliminates Chief Commercial Officer Position
6d ago
8K
NSPR
InspireMD Receives Nasdaq Notice on Bid Price Compliance
PremiumCompany Announcements
InspireMD Receives Nasdaq Notice on Bid Price Compliance
12d ago
8K
NSPR
InspireMD Reports Strong 30-Day Results From CGUARDIANS II Trial
PremiumCompany Announcements
InspireMD Reports Strong 30-Day Results From CGUARDIANS II Trial
2M ago
8K
NSPR
InspireMD enrolls first patient in CGUARDIANS III study
PremiumThe Fly
InspireMD enrolls first patient in CGUARDIANS III study
2M ago
NSPR
InspireMD Shareholders Approve Stock Increase and Board Slate
PremiumCompany Announcements
InspireMD Shareholders Approve Stock Increase and Board Slate
2M ago
8K
NSPR
InspireMD Balances Fast Growth With U.S. Setback
PremiumCompany AnnouncementsInspireMD Balances Fast Growth With U.S. Setback
3M ago
NSPR
InspireMD price target lowered to $3 from $4 at Piper Sandler
Premium
The Fly
InspireMD price target lowered to $3 from $4 at Piper Sandler
3M ago
NSPR
InspireMD reports Q1 EPS (16c), consensus (18c)
Premium
The Fly
InspireMD reports Q1 EPS (16c), consensus (18c)
3M ago
NSPR
InspireMD price target lowered to $4 from $5 at Lake Street
PremiumThe Fly
InspireMD price target lowered to $4 from $5 at Lake Street
3M ago
NSPR
InspireMD withdrawing prior FY26 revenue guidance
PremiumThe Fly
InspireMD withdrawing prior FY26 revenue guidance
3M ago
NSPR
InspireMD initiates voluntary U.S. recall of CGuard Prime 135 cm system
PremiumThe Fly
InspireMD initiates voluntary U.S. recall of CGuard Prime 135 cm system
3M ago
NSPR
InspireMD Recalls CGuard Prime Delivery System, Pauses U.S. Launch
PremiumCompany Announcements
InspireMD Recalls CGuard Prime Delivery System, Pauses U.S. Launch
3M ago
8K
NSPR
InspireMD announces FDA approval of IDE application for CGUARDIANS III study
PremiumThe FlyInspireMD announces FDA approval of IDE application for CGUARDIANS III study
3M ago
NSPR
InspireMD Establishes New $75 Million ATM Program
Premium
Company Announcements
InspireMD Establishes New $75 Million ATM Program
4M ago
8K
NSPR
InspireMD’s Growth Hinges on Real CAS Market Size and Physician Adoption
Premium
Company Announcements
InspireMD’s Growth Hinges on Real CAS Market Size and Physician Adoption
5M ago
NSPR
Midday Fly By: General Mills reports downbeat Q3, Macy’s reports Q4 beat
PremiumThe Fly
Midday Fly By: General Mills reports downbeat Q3, Macy’s reports Q4 beat
5M ago
M
CF
Morning Movers: Macy’s rises, General Mills slips after quarterly earnings
PremiumThe Fly
Morning Movers: Macy’s rises, General Mills slips after quarterly earnings
5M ago
M
WB
InspireMD Reports Strong Q4 2025 Growth and Expansion
PremiumCompany Announcements
InspireMD Reports Strong Q4 2025 Growth and Expansion
5M ago
8K
NSPR
InspireMD reports Q4 EPS (14c), consensus (19c)
PremiumThe Fly
InspireMD reports Q4 EPS (14c), consensus (19c)
5M ago
NSPR
InspireMD sees FY26 revenue $13M-$15M, consensus $14.55M
PremiumThe FlyInspireMD sees FY26 revenue $13M-$15M, consensus $14.55M
5M ago
NSPR
Is NSPR a Buy, Before Earnings?
Premium
Pre-Earnings
Is NSPR a Buy, Before Earnings?
5M ago
NSPR
InspireMD Announces Planned Departure of Chief Operating Officer
Premium
Company Announcements
InspireMD Announces Planned Departure of Chief Operating Officer
5M ago
8K
NSPR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >